Evaluation of biological pathways involved in chemotherapy response in breast cancer.

Breast Cancer Res · 2008 · PMC2397539 · PMID 18445275

Europe PMC DOI

hedged sentence

0.0600

closest p · 1.2× alpha

0.0600

boldest claim

The sentences

borderline significantP = 0.06so close (0.05 < p ≤ 0.1)

In ER + tumors, one of the two probe sets ('212023_s_at') showed borderline significant overexpression in the pCR group ( P = 0.06).

also in 11,409 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.